Trial Profile
A Randomized Controlled Trial of Midodrine During Recovery Phase From Septic Shock
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2017
Price :
$35
*
At a glance
- Drugs Midodrine (Primary)
- Indications Hypotension
- Focus Therapeutic Use
- 01 Nov 2017 Planned End Date changed from 1 Aug 2018 to 1 Nov 2017.
- 01 Nov 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Nov 2017.
- 01 Nov 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.